iCAN: Israel-Cannabis And Headquarters Announce Strategic Partnership

iCANN logo

ISRAEL: iCAN: Israel-Cannabis, Israel’s leading cannabis incubator and Headquarters (HQ), a Los Angeles based product accelerator and cannabis license holder with distribution and manufacturing facilities, have formed a strategic partnership to identify the most innovative Israeli cannabis companies and products, and provide them with access to the California market, via distribution, sales and marketing support. Saul Kaye, Read the full article…

iCAN: Israel-Cannabis CEO Saul Kaye Comments on New Israeli Cannabis Initiatives

Saul Kaye, iCan

ISRAEL: Kupat Holim Meuhedet, Israel’s third largest health maintenance organization (HMO), announced yesterday that it was opening an internal cannabis unit using a digitalized system that will allow for significantly faster medical cannabis approval for patients in need. In the framework of the new independent unit, the family doctor will transfer the request of the Meuhedet Read the full article…

China’s Thalys And iCAN: Israel-Cannabis Sign MOU For Co-Investment In Cannabis & Hemp Related Startups

Israel China Cannabis

ISRAEL: Thalys Medical Technology, a leading Chinese healthcare conglomerate listed on the Shanghai Stock Exchange (603716.SS), signed a Memorandum of Understanding with iCAN Israel-Cannabis, Israel’s leading medical cannabis incubator. Thalys and iCAN will come together to create a unique partnership to advance the development of early stage incubated companies that focus on the creation of medical technology, Read the full article…

iCAN Secures Financing Through A Convertible Loan Of CAD $4 million (US $3 million)

l to r. Jesse Kaplan, Plaza Capital, Sruli Weinreb, Plaza Capital, Saul Kaye, CEO, iCAN: Israel-Cannabis.signing the agreement.

ISRAEL: iCAN: Israel-Cannabis has announced that it has issued a secured convertible loan in the amount of CAD $4,000,000 to a group of investors led by Plaza Capital. The principal amount of each Convertible Security, plus accrued interest shall be convertible, for no additional consideration, into common shares of the Company at the option of the holders at Read the full article…

CannaTech Tel Aviv 2019 Returns April 1-3, 2019

CannaTech Tel Aviv

ISRAEL: Israel’s CannaTech conference returns to Tel Aviv, the global capital of medical cannabis –  a place where innovative Israeli researchers and scientists, high tech experts and “Start-Up Nation” entrepreneurs have fused their knowledge and skills with other world leaders in the industry to develop cutting edge expertise. The main events will take place at Trask, in the Read the full article…

Global Science & Business Leaders Converge For Panama’s First Medical Cannabis Conference February 12-13, 2019

CannaTech

ISRAEL: The world’s leading cannabis researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech Panama, Panama’s first ever international Summit for Accelerating Medical Cannabis Innovation. The main event will take place February 12-13, 2019 at the Central Hotel in Casco Viejo. According to Saul Read the full article…

New Study: Children With Autism See Improvement After Treatment With Tikun Olam High-CBD, Low-THC Medical Cannabis

Tikun Olam

NEW YORK: Children with Autism Spectrum Disorder (ASD) see a “significant” improvement in symptoms and less reliance on other medications after treatment with Tikun Olam’s Avidekel™ medical cannabis, as confirmed by a new study published in Scientific Reports. The two-year study, “Real Life Experience Of Medical Cannabis Treatment In Autism: Analysis Of Safety And Efficacy,” followed 188 Read the full article…

Greater Cannabis Company Inks Distribution Agreement With iCAN: Israel Cannabis

Greater Cannabis Company

ISRAEL: The Greater Cannabis Company, a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, has entered into a letter of intent with iCAN Cannabis  to expand distribution of its eluting patch platform into key global markets. The eluting patch platform is an innovative delivery system, which uses a patented Read the full article…

MJNews Exclusive Interview With Saul Kaye, CEO/Founder iCAN: Israel Cannabis

Saul Kaye, iCan

Since the 1960s, Israel has led the world in medical cannabis research. Now, as international markets emerge for legal medical cannabis, the country is poised to become a major global player.  Recently, the Israeli Parliament caused a great deal of industry excitement when it passed a bill that would pave the way for Israel to become an exporter of both Read the full article…

iCAN: Israel Cannabis CEO: “Cannabis to Become as Important to Israel’s Economy as High-Tech”

israel-flag-iflag-WKFrGh

ISRAEL: In a long-awaited move, the Knesset, Israel’s Parliament, has finally approved the export of medical cannabis allowing Israel to fully participate in the exploding cannabis industry world-wide. Saul Kaye, CEO of iCAN: Israel-Cannabis issued the following statement: “This is a long overdue but welcome development.  iCAN has been diligently working together with Israeli regulators to further the growth of the cannabis industry Read the full article…